Andy I. Chen
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Oncology top 1%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
Papers in
-
- Lymphoma Diagnosis and Treatment 46
- Oncology 47
- CAR-T cell therapy research 29
- Viral-associated cancers and disorders 11
- HER2/EGFR in Cancer Research 6
- Co-authors
- Arlene H. Sharpe (3 shared papers)Veronika Bachanová (10 shared papers)Tamás Masszi (7 shared papers)Craig H. Moskowitz (7 shared papers)Jan Andrzej Walewski (7 shared papers)John William Sweetenham (7 shared papers)Muneer Hyder Abidi (7 shared papers)Jerzy Hołowiecki (7 shared papers)
- Journals
- Blood (23 papers)Transplantation and Cellular Therapy (13 papers)Blood Advances (6 papers)British Journal of Haematology (4 papers)American Journal of Hematology (2 papers)
- Partner nations
- United StatesItalyPoland
In The Last Decade
Andy I. Chen
74 papers receiving 3.4k citations
Andy I. Chen's Hit Papers
Peers
Comparison fields: 5 of 85
- Pathology and Forensic Medicine 1.8k
- Oncology 2.1k
- Genetics 527
- Immunology 754
- Neurology 479
Countries citing papers authored by Andy I. Chen
This map shows the geographic impact of Andy I. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy I. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy I. Chen more than expected).
Fields of papers citing papers by Andy I. Chen
This network shows the impact of papers produced by Andy I. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy I. Chen. The network helps show where Andy I. Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Andy I. Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2015 | 573 |
| 2 | Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial Hit paper breakdown → | 2021 | 414 |
| 3 | 1999 | 268 | |
| 4 | 2019 | 212 | |
| 5 | 2018 | 196 | |
| 6 | 2014 | 124 | |
| 7 | 2016 | 111 | |
| 8 | 2019 | 110 | |
| 9 | 2002 | 100 | |
| 10 | 2017 | 99 | |
| 11 | 2003 | 96 | |
| 12 | 2008 | 91 | |
| 13 | 2018 | 78 | |
| 14 | 2016 | 78 | |
| 15 | 2024 | 72 | |
| 16 | 2021 | 59 | |
| 17 | 2018 | 57 | |
| 18 | 2021 | 52 | |
| 19 | 2022 | 42 | |
| 20 | 2022 | 39 |
About Andy I. Chen
Andy I. Chen is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Hematology and Immunology, having authored 78 papers that have together received 3.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (46 papers), CAR-T cell therapy research (29 papers), Chronic Lymphocytic Leukemia Research (14 papers), Viral-associated cancers and disorders (11 papers), Integrated Circuits and Semiconductor Failure Analysis (6 papers), HER2/EGFR in Cancer Research (6 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.8k citations), Oncology (2.1k citations), Genetics (527 citations), Immunology (754 citations) and Neurology (479 citations). Andy I. Chen has collaborated with scholars based in United States, Italy and Poland. Frequent co-authors include Arlene H. Sharpe, Veronika Bachanová, Tamás Masszi, Craig H. Moskowitz, Jan Andrzej Walewski, John William Sweetenham, Muneer Hyder Abidi, Jerzy Hołowiecki, Patrick J. Stiff and Auayporn P. Nademanee. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Blood Advances, British Journal of Haematology and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.